Semnur Pharmaceuticals, Inc. Convertible Notes Payable
Semnur Pharmaceuticals, Inc. (SMNR) had Convertible Notes Payable of $825.00 thousand as of 2023-07-11, per its 10-Q filed 2025-08-15.
Financial Statements › Balance Sheet › Liabilities › Long-Term Debt, Unclassified › Notes and Loans Payable
us-gaap:ConvertibleNotesPayable · last filed 2025-08-15
- 2023-07-11: Convertible Notes Payable $825.00K.
| Period end | Convertible Notes Payable |
|---|---|
| 2023-07-11 | $825.00K 10-Q · filed 2025-08-15 |